Last reviewed · How we verify
NCT07400978: Lupis
An At-distance and Online Intervention to Promote Parental Involvement and Self-regulation
NA trial testing Lupis program: parental intervention to promote self-regulation in children in Parental Involvement in 150 participants. Participants enrolled and being followed up; not accepting new ones.
30 June 2025
Quick facts
| Lead sponsor | University of Minho |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 7 October 2024 |
| Primary completion | 30 June 2025 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Lupis program: parental intervention to promote self-regulation in children
- Parental intervention on study methods
Conditions studied
- Parental Involvement — all drugs for Parental Involvement →
- Self-regulation in Children — all drugs for Self-regulation in Children →
Sponsor
University of Minho
Who can join
Eligibility, any sex, with Parental Involvement or Self-regulation in Children. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Parents play a significant role in their children's development and learning. Parental involvement (PI) is characterized by behavioral profiles that are manifested in activities at home (e.g., helping with homework) and school (e.g., participating in meetings with teachers). Involved parents tend to create more opportunities for their children to develop different competencies. These competencies are relevant to children's academic success, namely, the knowledge and use of self-regulation (SR) strategies. SR strategies enable children to take control and responsibility for their behaviors, thoughts, and emotions, thereby achieving a goal (e.g., an academic goal), which in turn leads to higher academic performance and well-being. Extensive research has identified PI and SR as strong predictors of children's academic success, underscoring the need to promote them actively. Thus, the main goal of this investigation - the Lupis program - is to develop and evaluate the efficacy of an at-distance and online intervention program for parents of 1st and 2nd grade elementary school students. The Lupis will be a narrative-based intervention, utilizing wise intervention techniques in its design. The Lupis program will aim to promote PI and, consequently, SR competencies in children. In general, it is expected to develop an effective intervention program to promote PI and SR competencies in children. Additionally, Lupis is expected to help parents and children prevent and address the challenges of transitioning from preschool to elementary school with essential competencies for children's learning and academic success.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07400978
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Minho trials
Trials by the same sponsor.
- NCT07356206 — Between Paws and Affections - Impact of Dog-Assisted Therapy in Fibromyalgia Patients · NA · active not recruiting
- NCT06050486 — A Mentalization-based Intervention for Children of Parent(s) With Borderline Personality Disorder · NA · active not recruiting
- NCT05946083 — The Brain, the Bug, and the Binge: the Interplay Between Binge Drinking, Gut Microbiota, and Brain Functioning · Phase 2 · recruiting
- NCT05395364 — A Health Promotion Intervention for Vulnerable School · NA · completed
- NCT04247516 — A Study Protocol for an Online Intervention to Promote School Engagement · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07400978 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minho
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07400978.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing